This study quantified utility weights and clarified the magnitude of the impact of AEs in Japanese patients with mTNBC. These findings highlight the importance of considering HRQL decline when evaluating the cost-effectiveness of mTNBC treatments. These data can inform future cost-effectiveness analyses for various mTNBC drugs while considering the preferences of the Japanese population. They can also be used to propose the optimal treatment for mTNBC.
Yamaguchi et al. (Sun,) studied this question.